These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5109250)

  • 1. Central action of phentolamine administered intraventricularly in the rat.
    Kleinrok Z; Zebrowska-Lupina I
    Psychopharmacologia; 1971; 20(4):348-54. PubMed ID: 5109250
    [No Abstract]   [Full Text] [Related]  

  • 2. The central action of intraventricularly (ivc) administered propranolol and phentolamine in rat.
    Kleinrok Z; Ksiazek A; Przesmycki K; Kolasa K
    Pol J Pharmacol Pharm; 1975; 27(4):405-12. PubMed ID: 1166021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
    Lapin IP; Oxenkrug GF; Azbekyan SG
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):350-61. PubMed ID: 4260601
    [No Abstract]   [Full Text] [Related]  

  • 5. Some central effects of diethyldithiocarbamate administered intraventricularly in rats.
    Kleinrok Z; Zebrowska I; Wielosz M
    Neuropharmacology; 1970 Sep; 9(5):451-5. PubMed ID: 5477430
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of phentolamine administered intraventricularly on the blood pressure in rat.
    Kleinrok Z; Jagiello-Wójtowicz E; Zebrowska-Lupina I
    Acta Biol Med Ger; 1972; 29(1):171-7. PubMed ID: 4649296
    [No Abstract]   [Full Text] [Related]  

  • 7. The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):287-95. PubMed ID: 4859523
    [No Abstract]   [Full Text] [Related]  

  • 8. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of 1-(o-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (alprenolol) on the central nervous system of the rat.
    Herman ZS; Kmieciak-Kolada K; Drybański A; Sokola A; Trzeciak H; Chruściel TL
    Psychopharmacologia; 1971; 21(1):66-73. PubMed ID: 4398073
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of guanethidine on rat brain serotonin and norepinephrine.
    Cox RH; Maickel RP
    Life Sci; 1969 Dec; 8(23):1319-24. PubMed ID: 5360061
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cntral site for the hypothermic effects of (+)-amphetamine sulphate and p-hydroxyamphetamine hydrobromide in mice.
    McCullough DO; Milberg JN; Robinson SM
    Br J Pharmacol; 1970 Oct; 40(2):219-26. PubMed ID: 5492894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behaviour in the rat.
    Herman ZS; Trzeciak H; Chruściel TL; Kmieciak-Kolada K; Drybański A; Sokola A
    Psychopharmacologia; 1971; 21(1):74-81. PubMed ID: 5105870
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacological effects of ouabain administered intracerebrally to conscious mice.
    Doggett NS; Spencer PS; Turner TA
    Br J Pharmacol; 1970 Sep; 40(1):138P-139P. PubMed ID: 5487004
    [No Abstract]   [Full Text] [Related]  

  • 16. The central action of histamine. 3. The effect of antazoline and thenalidine on the brain noradrenaline and 5-hydroxytryptamine levels and behavior of rats receiving histamine intraventricularly.
    Kleinrok Z; Jagiello-Wójtowicz E; Kolasa K
    Pol J Pharmacol Pharm; 1973; 25(6):519-24. PubMed ID: 4151860
    [No Abstract]   [Full Text] [Related]  

  • 17. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
    Vetulani J; Reichenberg K; Wiszniowska G
    Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigations into the mechanism of the influence of kinins on the action of amphetamine.
    Moniuszko-Jakoniuk J; Kościelak M; Wiśniewski K
    Pharmacology; 1978; 16(2):89-97. PubMed ID: 619367
    [No Abstract]   [Full Text] [Related]  

  • 20. Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5,6 dihydroxytryptamine.
    Diaz J; Ellison G; Masuoka D
    Psychopharmacologia; 1974 Jun; 37(1):67-79. PubMed ID: 4414929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.